An expert in oncology and pathology serving as an expert witness with more than 20 years of professional experience in cancer biology and tumor pathology. The expert’s work focuses on the molecular mechanisms of cancer development, including the role of oncogenes in initiating and sustaining tumorigenesis, as well as the biological processes underlying tumor dormancy and tumor regression. The expert has more than 10 years of experience providing litigation support, including consultations, deposition testimony, and courtroom testimony in matters involving oncology and cancer pathology.

The expert’s research and professional work focus on oncogene-driven cancers and the biological mechanisms that influence tumor progression and reversal. Areas of expertise include the study of oncogenes in tumorigenesis, mechanisms of tumor regression following oncogene inactivation, and the biological processes that allow tumors to escape oncogene dependence. Research interests also include malignancies such as lymphoma, leukemia, osteogenic sarcoma, and hepatocellular carcinoma.

In addition to research responsibilities, the expert holds academic appointments in both oncology and pathology and has served as a professor in these disciplines. The expert is affiliated with multidisciplinary biomedical research programs and cancer research institutes focused on translational cancer research and clinical investigation. These roles involve laboratory research programs examining molecular pathways that regulate cancer development and therapeutic response.

The expert directs a cancer research laboratory focused on understanding how oncogenes initiate tumor formation and sustain malignant growth, as well as how the inactivation of specific oncogenes can trigger tumor regression. Research programs have developed experimental models that enable conditional activation and deactivation of oncogenes to study cancer development and therapeutic targeting. This work has contributed to advances in understanding oncogene dependence and tumor dormancy.

Professional credentials include a Doctor of Medicine (M.D.) and Doctor of Philosophy (Ph.D.) in medicine and molecular biology. The expert has received multiple professional honors recognizing contributions to cancer research and clinical investigation and has authored numerous peer-reviewed scientific publications addressing oncogenes, tumor biology, and cancer therapeutics.